237 related articles for article (PubMed ID: 22842243)
1. Comparative evaluation of expression of proliferating cell nuclear antigen in variants of ameloblastoma and ameloblastic carcinoma.
Maya R; Sekar B; Murali S
Indian J Dent Res; 2012; 23(1):15-9. PubMed ID: 22842243
[TBL] [Abstract][Full Text] [Related]
2. Comparative immunohistochemical study of ameloblastoma and ameloblastic carcinoma.
Yoon HJ; Jo BC; Shin WJ; Cho YA; Lee JI; Hong SP; Hong SD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Dec; 112(6):767-76. PubMed ID: 22014999
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy of ameloblastoma and ameloblastic carcinoma of the jaws. Analysis by image and flow cytometry.
Müller S; DeRose PB; Cohen C
Arch Pathol Lab Med; 1993 Nov; 117(11):1126-31. PubMed ID: 8239934
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas.
Meer S; Galpin JS; Altini M; Coleman H; Ali H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Feb; 95(2):213-21. PubMed ID: 12582363
[TBL] [Abstract][Full Text] [Related]
5. Expression of tenascin and nucleolar organizer region in ameloblastoma and ameloblastic fibroma.
Carnelio S; Vij H
J Oral Pathol Med; 2010 Mar; 39(3):223-9. PubMed ID: 19943856
[TBL] [Abstract][Full Text] [Related]
6. Gene mutation analysis and immunohistochemical study of beta-catenin in odontogenic tumors.
Miyake T; Tanaka Y; Kato K; Tanaka M; Sato Y; Ijiri R; Inayama Y; Ito Y; Aoki S; Kawabe R; Tohnai I
Pathol Int; 2006 Dec; 56(12):732-7. PubMed ID: 17096730
[TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen (PCNA) and p53 protein expression in ameloblastoma and adenomatoid odontogenic tumor.
Barboza CA; Pereira Pinto L; Freitas Rde A; Costa Ade L; Souza LB
Braz Dent J; 2005; 16(1):56-61. PubMed ID: 16113935
[TBL] [Abstract][Full Text] [Related]
8. Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma.
Bologna-Molina R; Mosqueda-Taylor A; Lopez-Corella E; de Almeida OP; Carrasco-Daza D; Farfán-Morales JE; Molina-Frechero N; Damián-Matsumura P
Pathol Int; 2009 Apr; 59(4):229-33. PubMed ID: 19351365
[TBL] [Abstract][Full Text] [Related]
9. Ameloblastic carcinoma, secondary type: a case report.
Karakida K; Aoki T; Sakamoto H; Takahashi M; Akamatsu T; Ogura G; Sekido Y; Ota Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Dec; 110(6):e33-7. PubMed ID: 21112523
[TBL] [Abstract][Full Text] [Related]
10. Histochemistry of Ki-67 antigen in ameloblastomas.
Nagao Y; Wato M; Tanaka A
J Osaka Dent Univ; 1999 Oct; 33(2):53-7. PubMed ID: 10863475
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors.
Bologna-Molina R; Mosqueda-Taylor A; Molina-Frechero N; Mori-Estevez AD; Sánchez-Acuña G
Med Oral Patol Oral Cir Bucal; 2013 Mar; 18(2):e174-9. PubMed ID: 23229269
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study on proliferating cell nuclear antigen expression in ameloblastomas.
Kim J; Yook JI
Eur J Cancer B Oral Oncol; 1994; 30B(2):126-31. PubMed ID: 7913362
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumor.
Salehinejad J; Zare-Mahmoodabadi R; Saghafi S; Jafarian AH; Ghazi N; Rajaei AR; Marouzi P
J Oral Sci; 2011 Jun; 53(2):213-7. PubMed ID: 21712626
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
[TBL] [Abstract][Full Text] [Related]
15. IMMUNOEXPRESSION OF TWIST IN DIFFERENT MORPHOLOGICAL VARIANTS OF AMELOBLASTOMAS.
Khalil E; Rehman A; Ahmed F
J Ayub Med Coll Abbottabad; 2015; 27(2):296-303. PubMed ID: 26411101
[TBL] [Abstract][Full Text] [Related]
16. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors.
Kumamoto H; Ohki K
J Oral Pathol Med; 2010 Jan; 39(1):87-93. PubMed ID: 19659474
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
[TBL] [Abstract][Full Text] [Related]
18. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in unicystic ameloblastoma.
Li TJ; Browne RM; Matthews JB
Histopathology; 1995 Mar; 26(3):219-28. PubMed ID: 7797199
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of p16 tumor-suppressor gene in ameloblastic carcinoma, ameloblastoma, and dental follicles.
Khojasteh A; Khodayari A; Rahimi F; Ghaderian MH; Jafarian M; Nayebi A; Akbarzadeh Najar R; Tabatabayipanah A; Jahangirnia A
J Oral Maxillofac Surg; 2013 Jan; 71(1):62-5. PubMed ID: 22705216
[TBL] [Abstract][Full Text] [Related]
20. The dilemma of extensive unilocular radiolucent lesions of the jaws - value of immunohistochemistry as a diagnostic marker and prognostic Indicator.
Jeyaraj P
Ann Diagn Pathol; 2019 Jun; 40():105-135. PubMed ID: 31077874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
